We are committed to providing physicians with clinical tools to help address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of autoimmune Connective Tissue Disease (CTD).

Exagen is committed to providing physicians with products that address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of ARD/CTD so they, in turn, can help more patients in need. We will continue translating our discovery and development into real solutions that are safe, reliable and cost effective.